AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 261 min read$BRO

Brown & Brown, Inc. (BRO) Posts Q3 Revenue $1.7B, EPS $0.67

Brown & Brown, Inc. reported Q3 2026 revenue of $1.7B, up 7.4% YoY, with organic growth of 1.2%. EPS was $0.67, and adjusted EPS was $1.07. The company cited a tough pricing backdrop.

Original reporting
tradingview.com
Published Oct 26, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Brown & Brown, Inc. (BRO) Posts Q3 Revenue $1.7B, EPS $0.67 — source image
Source · tradingview.com
Decision brief

The 30-second read

$BRONeutralHigh
01

Why it matters

The Q3 results provide fresh data for valuation models and may trigger modest price movement.

02

Market read

First‑report earnings release with new revenue and EPS figures, relevant for traders monitoring insurance stocks.

03

What to watch

Accession synergies and margin trajectory remain unclear, which could affect future earnings.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Brown & Brown is a publicly traded insurance intermediary that releases quarterly earnings.

Company-level read

Ticker impact

$BRONeutralHigh confidence
Context

Brown & Brown reported Q3 2026 revenue of $1.7B and diluted EPS of $0.67, a 7.4% YoY revenue increase.

Expected impact

potential modest upside as the market prices in the revenue growth and EPS beat

Evidence & confidence

The numbers are fresh and better than consensus, but organic growth is soft, limiting a strong rally.

Market effects

Sector

Insurance sector may see slight positive bias from a mid‑cap insurer posting solid top‑line growth.

Regional

U.S. market participants may adjust exposure to property‑casualty insurers.

Global

Limited; impact confined to U.S. insurance equities.

Counterpoint

What could challenge this read

Soft organic growth and pricing pressure could signal a slowdown, prompting a short‑term pullback.

Key entities

  • company
    Brown & Brown, Inc.

    Insurance intermediary reporting Q3 2026 results.

Read at source← All news

StoryBrown & Brown reports Q3 growth as organic expansion and margins weaken

Also covered by

5 outlets

Related articles

OCT 27
$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

finance.yahoo.com3 min
OCT 27
$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

finance.yahoo.com3 min
OCT 27
$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

finance.yahoo.com2 min
OCT 27
$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.

investing.com2 min
OCT 27
$BROMed

Why Brown & Brown (BRO) stock is trading lower today

Brown & Brown (BRO) shares fell 4.9% after reporting Q3 2026 revenue of $1.73B, up 7.4% YoY, but with slowing organic growth and margin compression. CEO Powell Brown noted declines in excess-and-surplus property rates and expected further decreases in 2027. The stock is down 13.4% YTD, trading at $67.25, 23.4% below its 52-week high.

financialcontent.com2 min